Fragile X Syndrome (FXS), also called FX syndrome or Martin-Bell syndrome, is a genetic disorder that affects a child's development, behaviour, appearance, and health. It is the most common inherited ...
“These findings demonstrate a gross under-identification among male youth with fragile X syndrome,” says Klusek, an associate professor of communication sciences and disorders who studies the genetic ...
In a comprehensive Genomic Press Interview, researchers from the University of Texas Health Science Center at San Antonio and Hirosaki University have uncovered critical new insights into the ...
A new study suggests a potential molecular strategy for treating fragile X syndrome, an inherited neurodevelopmental disorder that causes autism spectrum disorder and intellectual disability. This ...
Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ...
Joel Richter receives funding from NIH and FRAXA. Sneha Shah receives funding from the FRAXA Research Foundation. Fragile X syndrome is a genetic disorder caused by a mutation in a gene that lies at ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quiver Bioscience (“Quiver”) and QurAlis Corporation (“QurAlis”), today announced that the companies have entered into a research collaboration to advance a novel ...
Servier acquires KER-0193, a potential treatment for Fragile X syndrome, developed by Kaerus Bioscience, a Medicxi company KER-0193, a novel, orally bioavailable small molecule, was granted Orphan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback